Results for tag: "Praluent"

Praluent is a cardiovascular drug used to treat high levels of low-density lipoprotein (LDL) cholesterol. It is a monoclonal antibody that works by blocking the action of a protein called PCSK9, which helps regulate the amount of LDL cholesterol in the blood. Praluent is administered as an injection and is used in combination with diet and exercise to reduce the risk of cardiovascular events such as heart attack and stroke. It is approved for use in adults with primary hyperlipidemia, homozygous familial hypercholesterolemia, and mixed dyslipidemia. The Praluent market is highly competitive, with several major players offering similar products. These include Sanofi, Regeneron Pharmaceuticals, Amgen, and Pfizer. Other companies in the market include AstraZeneca, Merck, and Novartis. Show Less Read more